EUVIMEDEUVIMED entdecken
Crossref

Tetrandrine nanocrystals for rheumatoid arthritis: enhanced therapeutic efficacy associated with reduced JAK1 and STAT3 expression

Guangzhao Wang, Jian Mo, Wenxiu Huang, Lizhen Feng, Dongyi Huang, Tingting Huang, Yang Li, Wei Wang, Guangyi Meng, Xingzhen Huang iD

Journal of Pharmacy and Pharmacology · 2026

DOI: 10.1093/jpp/rgag083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2026. Verfasst von Guangzhao Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Guangxi Medical University, Nanning, Guangxi 530000, China. Hauptthemen laut MEDLINE: Benzylisoquinolines, STAT3 Transcription Factor, Nanoparticles, Arthritis, Rheumatoid. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangxi Natural Science Foundation, Health Commission of Guangxi Zhuang Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by persistent pain and a significant decline in quality of life. Tetrandrine (Tet), a bisbenzylisoquinoline alkaloid, exhibits significant antipyretic, analgesic, and anti-inflammatory effects. However, its low solubility in water limits its clinical applications.

Objective

This study focuses on the preparation of tetrandrine nanocrystals (Tet-NCs) using ultrasound technology and evaluates their therapeutic effects and potential mechanisms in a rat model of adjuvant arthritis (AA).

Methods

The AA model was induced using Freund’s complete adjuvant (FCA). Tet-NCs were prepared via ultrasound technology and administered at varying doses. The efficacy of Tet-NCs was compared with that of Tet tablets and indomethacin tablets. The assessed outcomes include joint swelling, arthritis scores, pathological changes in the joints, levels of inflammatory factors (interleukin-6, interleukin-1β, tumor necrosis factor-α, prostaglandin E2, cyclooxygenase-2, vascular endothelial growth factor A, and matrix metalloproteinase-3) in joint cavities and serum, as well as the angiogenesis in synovial tissues and the expression of key proteins—Janus kinase 1 (JAK1) and signal transducer and activator of transcription 3 (STAT3). Key findings Experimental data indicate that the average particle size of the optimized Tet-NCs is 124.30 nm, with a polydispersity index (PDI) of 0.27. The therapeutic effects of low-dose Tet-NCs were comparable to those of Tet tablets, while medium- and high-dose Tet-NCs were significantly more effective than Tet tablets in reducing ankle joint swelling, lowering inflammatory factors levels, and protecting joint structure, and showed no statistically significant difference from indomethacin under the tested conditions. Furthermore, the expression levels of JAK1 and STAT3 in the AA model were significantly reduced by both medium- and high-dose Tet-NCs (all P < .001).

Conclusion

This study demonstrates that Tet-NCs provide superior therapeutic effects in RA compared to conventional Tet tablets, and their mechanism of action may involve the regulation of inflammation through inhibition of the JAK1/STAT3 signaling pathway. Consequently, Tet-NCs show potential for further development as a novel anti-arthritic agent, although their clinical applicability remains to be validated in future studies. Clinical trial number: not applicable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzylisoquinolinesSTAT3 Transcription FactorNanoparticlesArthritis, RheumatoidJanus Kinase 1Arthritis, ExperimentalAnti-Inflammatory AgentsAnimalsRatsMaleRats, Sprague-DawleyIndomethacin

Stichwörter der Autor:innen

JAK1/STAT3nanocrystallinerheumatoid arthritistetrandrine

Substanzen

tetrandrineBenzylisoquinolinesSTAT3 Transcription FactorJanus Kinase 1Stat3 protein, ratJak1 protein, ratIndomethacinAnti-Inflammatory Agents

Autor:innen und Institutionen

  • School of Pharmacy, Guangxi Medical University, Nanning, Guangxi 530000, China.
  • Pharmacy Department, The Sixth Affiliated Hospital of Guangxi Medical University (The First People's Hospital of Yulin), Yulin 537000, China.
  • Interventional Ultrasound Department, The Sixth Affiliated Hospital of Guangxi Medical University (The First People's Hospital of Yulin), Yulin 537000, China.
  • Guangdong Institute of Arts and Sciences, Zhanjiang, Guangdong 524000, China.
  • Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation, Nanning, Guangxi 530000, China.

ORCID-Profile: Xingzhen Huang

Förderung

  • National Natural Science Foundation of China
  • Guangxi Natural Science Foundation
  • Health Commission of Guangxi Zhuang Autonomous Region

Zitieren

APA

Wang, G., Mo, J., Huang, W., Feng, L., Huang, D., Huang, T., Li, Y., Wang, W., Meng, G., & Huang, X. (2026). Tetrandrine nanocrystals for rheumatoid arthritis: enhanced therapeutic efficacy associated with reduced JAK1 and STAT3 expression. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgag083

Vancouver

Wang G, Mo J, Huang W, Feng L, Huang D, Huang T, et al. Tetrandrine nanocrystals for rheumatoid arthritis: enhanced therapeutic efficacy associated with reduced JAK1 and STAT3 expression. Journal of Pharmacy and Pharmacology. 2026. doi:10.1093/jpp/rgag083

BibTeX
@article{Wang2026,
  author = {Wang, Guangzhao and Mo, Jian and Huang, Wenxiu and Feng, Lizhen and Huang, Dongyi and Huang, Tingting and Li, Yang and Wang, Wei and Meng, Guangyi and Huang, Xingzhen},
  title = {Tetrandrine nanocrystals for rheumatoid arthritis: enhanced therapeutic efficacy associated with reduced JAK1 and STAT3 expression},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2026},
  doi = {10.1093/jpp/rgag083}
}
Kostenlos starten →